Published in Surv Ophthalmol on June 22, 2009
Glaucoma: genes, phenotypes, and new directions for therapy. J Clin Invest (2010) 1.39
Gene therapy for ocular diseases. Br J Ophthalmol (2010) 0.90
A Potential Application of Canaloplasty in Glaucoma Gene Therapy. Transl Vis Sci Technol (2013) 0.81
Application of canaloplasty in glaucoma gene therapy: where are we? J Ocul Pharmacol Ther (2014) 0.79
Exciting directions in glaucoma. Can J Ophthalmol (2014) 0.78
Republished review: Gene therapy for ocular diseases. Postgrad Med J (2011) 0.77
Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics. Indian J Pharm Sci (2010) 0.76
Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med (2008) 17.21
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol (2002) 16.89
Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med (2008) 15.30
The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators. Am J Ophthalmol (2000) 12.21
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A (1994) 8.13
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol (2006) 5.58
Strategies for silencing human disease using RNA interference. Nat Rev Genet (2007) 5.19
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med (2001) 4.02
Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer. Mol Ther (2008) 3.28
Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum Mol Genet (2001) 2.88
Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron (1994) 2.84
Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res (2006) 2.49
Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci (2006) 2.37
Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis. Mol Ther (2005) 2.27
Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci (2001) 2.15
TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci (2001) 2.04
Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest Ophthalmol Vis Sci (2006) 2.00
Gene mapping for primary open angle glaucoma. Clin Biochem (2005) 1.98
Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model. J Virol (1999) 1.95
Experimental glaucoma in the rhesus monkey. Invest Ophthalmol (1974) 1.94
Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci (2001) 1.88
How does nonpenetrating glaucoma surgery work? Aqueous outflow resistance and glaucoma surgery. J Glaucoma (2001) 1.83
Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res (2005) 1.82
Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size. J Virol (2002) 1.77
Production and purification of recombinant adeno-associated virus. Methods Enzymol (2000) 1.66
Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci U S A (1998) 1.60
Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci (1999) 1.60
Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res (1993) 1.58
Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation. Exp Eye Res (2002) 1.56
TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J Neurosci (2002) 1.51
Aqueous humor dynamics in the aging human eye. Am J Ophthalmol (1999) 1.44
Regulation of myosin light chain phosphorylation in the trabecular meshwork: role in aqueous humour outflow facility. Exp Eye Res (2005) 1.43
The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest Ophthalmol Vis Sci (2005) 1.40
Ultrahistochemical studies on tangential sections of the trabecular meshwork in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci (1981) 1.37
Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. Invest Ophthalmol Vis Sci (2006) 1.37
Effects of the Rho kinase inhibitor Y-27632 and the phosphatase inhibitor calyculin A on outflow facility in monkeys. Exp Eye Res (2005) 1.35
Gene delivery to the eye using adeno-associated viral vectors. Methods (2002) 1.35
Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice. Brain Res (2004) 1.35
Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells. A quantitative in vivo study. Invest Ophthalmol Vis Sci (1996) 1.34
Clostridium botulinum C3 ADP-ribosyltransferase. Curr Top Microbiol Immunol (1992) 1.33
Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV. Vision Res (1999) 1.30
Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility. Invest Ophthalmol Vis Sci (2004) 1.30
Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Mol Ther (2002) 1.26
Recombinant TIGR/MYOC increases outflow resistance in the human anterior segment. Invest Ophthalmol Vis Sci (2000) 1.26
Manometric calibration and comparison of TonoLab and TonoPen tonometers in rats with experimental glaucoma and in normal mice. J Glaucoma (2006) 1.25
Characterization of retinal damage in the episcleral vein cauterization rat glaucoma model. Exp Eye Res (2005) 1.24
Adeno-associated virus vectors: activity and applications in the CNS. J Neurosci Methods (2000) 1.23
A rat model of glaucoma induced by episcleral vein ligation. Exp Eye Res (2006) 1.19
Non-invasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo. J Gene Med (2001) 1.19
Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow. Mol Vis (2005) 1.18
Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration. Gene Ther (2003) 1.17
The effect of C3 transgene expression on actin and cellular adhesions in cultured human trabecular meshwork cells and on outflow facility in organ cultured monkey eyes. Mol Vis (2005) 1.16
The relation between the ciliary muscle and the trabecular meshwork and its importance for the effect of miotics on aqueous outflow resistance. A study in two contrasting monkey species, Macaca irus and Cercopithecus aethiops. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1967) 1.15
Cooperative effects of bcl-2 and AAV-mediated expression of CNTF on retinal ganglion cell survival and axonal regeneration in adult transgenic mice. Eur J Neurosci (2006) 1.15
Altered secretion of a TIGR/MYOC mutant lacking the olfactomedin domain. Biochim Biophys Acta (2000) 1.14
Neuroprotective effect of sulfhydryl reduction in a rat optic nerve crush model. Invest Ophthalmol Vis Sci (2005) 1.12
Effects of elevated intraocular pressure on mouse retinal ganglion cells. Vision Res (2005) 1.12
Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes. Invest Ophthalmol Vis Sci (2005) 1.11
Differential expression of matrix metalloproteinases in monkey eyes with experimental glaucoma or optic nerve transection. Brain Res (2003) 1.11
Effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with a contact lens-type electrode. Gene Ther (2005) 1.11
Gene transfer of dominant-negative RhoA increases outflow facility in perfused human anterior segment cultures. Mol Vis (2002) 1.08
In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest Ophthalmol Vis Sci (1995) 1.08
Heparin II domain of fibronectin uses alpha4beta1 integrin to control focal adhesion and stress fiber formation, independent of syndecan-4. J Biol Chem (2004) 1.08
Elevated intraocular pressure and transgenic applications in the mouse. J Glaucoma (2005) 1.07
Durable, safe, multi-gene lentiviral vector expression in feline trabecular meshwork. Mol Ther (2007) 1.07
Latrunculin-A increases outflow facility in the monkey. Invest Ophthalmol Vis Sci (1999) 1.07
H-7 disrupts the actin cytoskeleton and increases outflow facility. Arch Ophthalmol (1998) 1.06
The mechanism of aqueous humour formation. Clin Exp Optom (2002) 1.06
Caldesmon effects on the actin cytoskeleton and cell adhesion in cultured HTM cells. Exp Eye Res (2006) 1.06
Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy. Invest Ophthalmol Vis Sci (2007) 1.05
Caldesmon. Int J Biochem Cell Biol (1998) 1.05
The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice. Invest Ophthalmol Vis Sci (2005) 1.05
Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. Arch Ophthalmol (1999) 1.04
Caldesmon transgene expression disrupts focal adhesions in HTM cells and increases outflow facility in organ-cultured human and monkey anterior segments. Exp Eye Res (2006) 1.04
Preservation of aqueous outflow facility after second-generation FIV vector-mediated expression of marker genes in anterior segments of human eyes. Invest Ophthalmol Vis Sci (2002) 1.04
Effects of cholesterol-lowering statins on the aqueous humor outflow pathway. Invest Ophthalmol Vis Sci (2005) 1.03
Myocilin binding to Hep II domain of fibronectin inhibits cell spreading and incorporation of paxillin into focal adhesions. Exp Cell Res (2004) 1.01
Effect of heparin II domain of fibronectin on aqueous outflow in cultured anterior segments of human eyes. Invest Ophthalmol Vis Sci (2003) 1.01
Extracellular signal-regulated kinase 1/2 mediates survival, but not axon regeneration, of adult injured central nervous system neurons in vivo. J Neurochem (2005) 1.00
Effects of atropine and pilocarpine on aqueous humour dynamics in cynomolgus monkeys (Macaca irus). Exp Eye Res (1967) 1.00
Aqueous humor dynamics in ocular hypertensive patients. J Glaucoma (2002) 0.98
Ocular gene therapy: a review of nonviral strategies. Mol Vis (2006) 0.98
Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema. BioDrugs (2007) 0.97
Gene therapy for optic nerve disease. Eye (Lond) (2004) 0.97
Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. Mol Ther (2005) 0.97
Mechanisms of AAV transduction in glaucoma-associated human trabecular meshwork cells. J Gene Med (2006) 0.96
Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer. Mol Vis (2003) 0.95
Long-term in vivo inhibition of CNS neurodegeneration by Bcl-XL gene transfer. Mol Ther (2005) 0.95
Long-term, targeted genetic modification of the aqueous humor outflow tract coupled with noninvasive imaging of gene expression in vivo. Invest Ophthalmol Vis Sci (2004) 0.95
The ups and downs of adenovirus vectors. Bull N Y Acad Med (1996) 0.94
Stromelysin gene transfer into cultured human trabecular cells and rat trabecular meshwork in vivo. Invest Ophthalmol Vis Sci (2001) 0.94
Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptors--implications for gene therapy. Mol Ther (2002) 0.92
Gene therapy using p21WAF-1/Cip-1 to modulate wound healing after glaucoma trabeculectomy surgery in a primate model of ocular hypertension. Gene Ther (2004) 0.90
The role of protein kinase C in modulation of aqueous humor outflow facility. Exp Eye Res (2003) 0.90
Complex neurodegeneration in retina following moderate ischemia induced by bilateral common carotid artery occlusion in Wistar rats. Exp Eye Res (2005) 0.90
Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost. Invest Ophthalmol Vis Sci (2006) 0.89
Functional delivery of synthetic naked siRNA to the human trabecular meshwork in perfused organ cultures. Mol Vis (2007) 0.88
Adenovirus-mediated gene therapy using human p21WAF-1/Cip-1 to prevent wound healing in a rabbit model of glaucoma filtration surgery. Arch Ophthalmol (2002) 0.87
Herpes simplex virus mediated gene transfer to primate ocular tissues. Exp Eye Res (1999) 0.87
XIAP-mediated neuroprotection in retinal ischemia. Gene Ther (2006) 0.87
Viscocanalostomy in rhesus monkeys. Arch Ophthalmol (2004) 2.04
Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res (2003) 1.98
Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Surv Ophthalmol (2008) 1.94
Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res (2005) 1.82
Effect of low-dose latrunculin B on anterior segment physiologic features in the monkey eye. Arch Ophthalmol (2004) 1.58
Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J Virol (2006) 1.54
Research opportunities in vision: a report of the U.S.-Indo workshops on collaborative research. Invest Ophthalmol Vis Sci (2006) 1.46
Accommodative ciliary body and lens function in rhesus monkeys, I: normal lens, zonule and ciliary process configuration in the iridectomized eye. Invest Ophthalmol Vis Sci (2006) 1.39
Imaging and measurement in the eye: now and ahead. Optom Vis Sci (2012) 1.38
Effects of the Rho kinase inhibitor Y-27632 and the phosphatase inhibitor calyculin A on outflow facility in monkeys. Exp Eye Res (2005) 1.35
Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp Eye Res (2004) 1.35
The glaucoma research community and FDA look to the future: a report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium. Invest Ophthalmol Vis Sci (2009) 1.31
Recent developments in understanding the pathophysiology of elevated intraocular pressure. Curr Opin Ophthalmol (2006) 1.29
The role of the actomyosin system in regulating trabecular fluid outflow. Exp Eye Res (2008) 1.28
In vitro localization of TIGR/MYOC in trabecular meshwork extracellular matrix and binding to fibronectin. Invest Ophthalmol Vis Sci (2002) 1.25
The zonula, lens, and circumlental space in the normal iridectomized rhesus monkey eye. Invest Ophthalmol Vis Sci (2006) 1.23
Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol (2002) 1.22
Self-complementary AAV virus (scAAV) safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys. Invest Ophthalmol Vis Sci (2009) 1.16
The effect of C3 transgene expression on actin and cellular adhesions in cultured human trabecular meshwork cells and on outflow facility in organ cultured monkey eyes. Mol Vis (2005) 1.16
Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain. Exp Eye Res (2006) 1.16
Latrunculin B effects on trabecular meshwork and corneal endothelial morphology in monkeys. Exp Eye Res (2005) 1.13
Morphology and accommodative function of the vitreous zonule in human and monkey eyes. Invest Ophthalmol Vis Sci (2009) 1.12
Eyelid lymphatics II: a search for drainage patterns in the monkey and correlations with human lymphatics. Ophthal Plast Reconstr Surg (2002) 1.12
Lens diameter and thickness as a function of age and pharmacologically stimulated accommodation in rhesus monkeys. Exp Eye Res (2008) 1.11
Differential expression of matrix metalloproteinases in monkey eyes with experimental glaucoma or optic nerve transection. Brain Res (2003) 1.11
Functional and structural reversibility of H-7 effects on the conventional aqueous outflow pathway in monkeys. Exp Eye Res (2004) 1.09
Age-related changes in centripetal ciliary body movement relative to centripetal lens movement in monkeys. Exp Eye Res (2009) 1.07
Beta1 and beta3 integrins cooperate to induce syndecan-4-containing cross-linked actin networks in human trabecular meshwork cells. Invest Ophthalmol Vis Sci (2006) 1.07
Using HSV-1 genome phylogenetics to track past human migrations. PLoS One (2013) 1.06
Peptides containing membrane-transiting motifs inhibit virus entry. J Biol Chem (2002) 1.06
Caldesmon effects on the actin cytoskeleton and cell adhesion in cultured HTM cells. Exp Eye Res (2006) 1.06
Regulation of cross-linked actin network (CLAN) formation in human trabecular meshwork (HTM) cells by convergence of distinct beta1 and beta3 integrin pathways. Invest Ophthalmol Vis Sci (2009) 1.05
Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function. Invest Ophthalmol Vis Sci (2011) 1.05
Caldesmon transgene expression disrupts focal adhesions in HTM cells and increases outflow facility in organ-cultured human and monkey anterior segments. Exp Eye Res (2006) 1.04
Comparison of the Ahmed Glaucoma Valve, the Krupin Eye Valve with Disk, and the double-plate Molteno implant. J Glaucoma (2002) 1.04
Distribution of syndecans 1-4 within the anterior segment of the human eye: expression of a variant syndecan-3 and matrix-associated syndecan-2. Exp Eye Res (2004) 1.03
Prolonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway of nonhuman primates. Hum Gene Ther (2009) 1.02
Neurochemical correlates of cortical plasticity after unilateral elevated intraocular pressure in a primate model of glaucoma. Invest Ophthalmol Vis Sci (2003) 1.02
Effect of heparin II domain of fibronectin on aqueous outflow in cultured anterior segments of human eyes. Invest Ophthalmol Vis Sci (2003) 1.01
Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection. Antimicrob Agents Chemother (2008) 1.00
Primate glaucoma models. J Glaucoma (2005) 1.00
Extralenticular and lenticular aspects of accommodation and presbyopia in human versus monkey eyes. Invest Ophthalmol Vis Sci (2013) 1.00
Monkey organ-cultured anterior segments: technique and response to H-7. Exp Eye Res (2006) 0.99
Surgical intervention and accommodative responses, II: forward ciliary body accommodative movement is facilitated by zonular attachments to the lens capsule. Invest Ophthalmol Vis Sci (2008) 0.99
Multiplex sequencing of seven ocular herpes simplex virus type-1 genomes: phylogeny, sequence variability, and SNP distribution. Invest Ophthalmol Vis Sci (2011) 0.97
Cochlin expression in anterior segment organ culture models after TGFbeta2 treatment. Invest Ophthalmol Vis Sci (2008) 0.96
Advances in glaucoma treatment and management: outflow drugs. Invest Ophthalmol Vis Sci (2012) 0.96
Sialic acid on herpes simplex virus type 1 envelope glycoproteins is required for efficient infection of cells. J Virol (2007) 0.95
Aging of the human lens: changes in lens shape upon accommodation and with accommodative loss. J Opt Soc Am A Opt Image Sci Vis (2002) 0.95
Astrocyte and microglial activation in the lateral geniculate nucleus and visual cortex of glaucomatous and optic nerve transected primates. Mol Vis (2009) 0.95
Expression of ephrinB1 and its receptor in glaucomatous optic neuropathy. Br J Ophthalmol (2007) 0.94
Morphologic indication for proprioception in the human ciliary muscle. Invest Ophthalmol Vis Sci (2009) 0.94
Gene therapy for glaucoma: treating a multifaceted, chronic disease. Invest Ophthalmol Vis Sci (2002) 0.92
Surgical intervention and accommodative responses, I: centripetal ciliary body, capsule, and lens movements in rhesus monkeys of various ages. Invest Ophthalmol Vis Sci (2008) 0.91
Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys. J Ocul Pharmacol Ther (2009) 0.91
Identification of the active site in the heparin II domain of fibronectin that increases outflow facility in cultured monkey anterior segments. Invest Ophthalmol Vis Sci (2008) 0.91
Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma. Arch Ophthalmol (2005) 0.91
Heparin II domain of fibronectin mediates contractility through an alpha4beta1 co-signaling pathway. Exp Cell Res (2010) 0.91
Aqueous humor dynamics and trabecular meshwork and anterior ciliary muscle morphologic changes with age in rhesus monkeys. Invest Ophthalmol Vis Sci (2003) 0.91
A quantitative rabbit model of vaccinia keratitis. Invest Ophthalmol Vis Sci (2010) 0.90
Accommodative movements of the vitreous membrane, choroid, and sclera in young and presbyopic human and nonhuman primate eyes. Invest Ophthalmol Vis Sci (2013) 0.90
Addition of a C-terminal cysteine improves the anti-herpes simplex virus activity of a peptide containing the human immunodeficiency virus type 1 TAT protein transduction domain. Antimicrob Agents Chemother (2007) 0.90
Oxidative injury by peroxynitrite in neural and vascular tissue of the lateral geniculate nucleus in experimental glaucoma. Exp Eye Res (2005) 0.90
Molecular cloning and expression profiling of optineurin in the rhesus monkey. Invest Ophthalmol Vis Sci (2005) 0.89
Effect of daily prolonged ketamine anesthesia on intraocular pressure in monkeys. Curr Eye Res (2008) 0.89
COCH transgene expression in cultured human trabecular meshwork cells and its effect on outflow facility in monkey organ cultured anterior segments. Invest Ophthalmol Vis Sci (2009) 0.89
Identification of the minimal active sequence of an anti-influenza virus peptide. Antimicrob Agents Chemother (2011) 0.88
Corneal toxicity of cell-penetrating peptides that inhibit Herpes simplex virus entry. J Ocul Pharmacol Ther (2006) 0.88
Functional and anatomic consequences of subretinal dosing in the cynomolgus macaque. Arch Ophthalmol (2011) 0.88
Heritable features of the optic disc: a novel twin method for determining genetic significance. Invest Ophthalmol Vis Sci (2007) 0.88
Bioinformatic and statistical analysis of the optic nerve head in a primate model of ocular hypertension. BMC Neurosci (2008) 0.88
Effects of latrunculin B on outflow facility, intraocular pressure, corneal thickness, and miotic and accommodative responses to pilocarpine in monkeys. Trans Am Ophthalmol Soc (2004) 0.88
Adenovirus-mediated gene therapy using human p21WAF-1/Cip-1 to prevent wound healing in a rabbit model of glaucoma filtration surgery. Arch Ophthalmol (2002) 0.87
Effect of nitric oxide on anterior segment physiology in monkeys. Invest Ophthalmol Vis Sci (2013) 0.87
Androgen receptor and NFkB expression in human normal and glaucomatous optic nerve head astrocytes in vitro and in experimental glaucoma. Exp Eye Res (2005) 0.86
A cationic peptide, TAT-Cd°, inhibits herpes simplex virus type 1 ocular infection in vivo. Invest Ophthalmol Vis Sci (2013) 0.86
Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine. Vaccine (2011) 0.85
Effects of topical H-7 on outflow facility, intraocular pressure, and corneal thickness in monkeys. Arch Ophthalmol (2004) 0.85
Aqueous humor dynamics in monkeys in response to the kappa opioid agonist bremazocine. Trans Am Ophthalmol Soc (2007) 0.85
Accommodation and presbyopia: the ciliary neuromuscular view. Ophthalmol Clin North Am (2006) 0.85
The prostaglandin wars. Am J Ophthalmol (2003) 0.85
Factors affecting outflow facility calculations. Exp Eye Res (2006) 0.85
Gold standard medical therapy for glaucoma: defining the criteria identifying measures for an evidence-based analysis. Clin Ther (2004) 0.85
Multifocal visual evoked potentials in the anesthetized non-human primate. Curr Eye Res (2006) 0.84
Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant. Invest Ophthalmol Vis Sci (2011) 0.84
Serial multifocal electroretinograms during long-term elevation and reduction of intraocular pressure in non-human primates. Doc Ophthalmol (2010) 0.83
Innervation of the uvea by galanin and somatostatin immunoreactive axons in macaques and baboons. Exp Eye Res (2002) 0.83
Optical coherence tomography for the evaluation of retinal and optic nerve morphology in animal subjects: practical considerations. Vet Ophthalmol (2012) 0.83
Inhibition of herpes simplex virus type 1 infection by cationic beta-peptides. Antimicrob Agents Chemother (2008) 0.83
Benzalkonium chloride and glaucoma. J Ocul Pharmacol Ther (2013) 0.82
Dendrite plasticity in the lateral geniculate nucleus in primate glaucoma. Vision Res (2010) 0.82